nodes	percent_of_prediction	percent_of_DWPC	metapath
Caffeine—migraine—Prednisone—prostate cancer	0.198	1	CpDpCtD
Caffeine—PRKDC—prostate cancer	0.103	0.281	CbGaD
Caffeine—ATM—prostate cancer	0.0589	0.161	CbGaD
Caffeine—PIK3CD—prostate cancer	0.0538	0.147	CbGaD
Caffeine—PIK3CB—prostate cancer	0.0538	0.147	CbGaD
Caffeine—PIK3CA—prostate cancer	0.0417	0.114	CbGaD
Caffeine—CYP1B1—Flutamide—prostate cancer	0.0243	0.094	CbGbCtD
Caffeine—CYP1B1—Estrone—prostate cancer	0.0176	0.0679	CbGbCtD
Caffeine—CYP1B1—prostate cancer	0.0169	0.0464	CbGaD
Caffeine—CYP3A5—prostate cancer	0.0135	0.0369	CbGaD
Caffeine—CYP1A1—Flutamide—prostate cancer	0.0107	0.0412	CbGbCtD
Caffeine—CYP1B1—Mitoxantrone—prostate cancer	0.0104	0.0404	CbGbCtD
Caffeine—CYP1B1—Estradiol—prostate cancer	0.0101	0.039	CbGbCtD
Caffeine—CYP2E1—prostate cancer	0.00928	0.0254	CbGaD
Caffeine—CYP1A1—prostate cancer	0.00915	0.025	CbGaD
Caffeine—CYP1A1—Estrone—prostate cancer	0.0077	0.0298	CbGbCtD
Caffeine—CYP2C8—Nilutamide—prostate cancer	0.00742	0.0287	CbGbCtD
Caffeine—CYP3A5—Flutamide—prostate cancer	0.0064	0.0247	CbGbCtD
Caffeine—CYP2C8—Abiraterone—prostate cancer	0.00615	0.0238	CbGbCtD
Caffeine—CYP1B1—Docetaxel—prostate cancer	0.00602	0.0233	CbGbCtD
Caffeine—CYP2E1—Estrone—prostate cancer	0.00595	0.023	CbGbCtD
Caffeine—CYP3A4—prostate cancer	0.00584	0.016	CbGaD
Caffeine—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.00573	0.0222	CbGbCtD
Caffeine—CYP2C9—Bicalutamide—prostate cancer	0.00518	0.02	CbGbCtD
Caffeine—CYP2C9—Nilutamide—prostate cancer	0.00518	0.02	CbGbCtD
Caffeine—CYP1A2—Flutamide—prostate cancer	0.00476	0.0184	CbGbCtD
Caffeine—CYP2D6—Bicalutamide—prostate cancer	0.00473	0.0183	CbGbCtD
Caffeine—CYP3A5—Cabazitaxel—prostate cancer	0.00473	0.0183	CbGbCtD
Caffeine—ABCB1—Estramustine—prostate cancer	0.00467	0.0181	CbGbCtD
Caffeine—CYP3A5—Estrone—prostate cancer	0.00462	0.0179	CbGbCtD
Caffeine—CYP2C8—Cabazitaxel—prostate cancer	0.00455	0.0176	CbGbCtD
Caffeine—CYP1B1—Doxorubicin—prostate cancer	0.00449	0.0174	CbGbCtD
Caffeine—CYP1A1—Estradiol—prostate cancer	0.00442	0.0171	CbGbCtD
Caffeine—CYP2C8—Ethinyl Estradiol—prostate cancer	0.00396	0.0153	CbGbCtD
Caffeine—CYP2D6—Abiraterone—prostate cancer	0.00392	0.0152	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Estradiol—prostate cancer	0.00354	0.0137	CbGbCtD
Caffeine—CYP3A7—Estradiol—prostate cancer	0.00354	0.0137	CbGbCtD
Caffeine—CYP2E1—Mitoxantrone—prostate cancer	0.00354	0.0137	CbGbCtD
Caffeine—CYP1A2—Estrone—prostate cancer	0.00344	0.0133	CbGbCtD
Caffeine—CYP2C9—Estrone—prostate cancer	0.0031	0.012	CbGbCtD
Caffeine—ABCB1—Cabazitaxel—prostate cancer	0.00308	0.0119	CbGbCtD
Caffeine—CYP3A4—Bicalutamide—prostate cancer	0.00301	0.0116	CbGbCtD
Caffeine—ABCB1—Estrone—prostate cancer	0.00301	0.0116	CbGbCtD
Caffeine—CYP3A4—Estramustine—prostate cancer	0.0028	0.0108	CbGbCtD
Caffeine—ABCB1—Ethinyl Estradiol—prostate cancer	0.00268	0.0104	CbGbCtD
Caffeine—CYP3A5—Estradiol—prostate cancer	0.00266	0.0103	CbGbCtD
Caffeine—CYP2C8—Estradiol—prostate cancer	0.00255	0.00988	CbGbCtD
Caffeine—CYP3A4—Abiraterone—prostate cancer	0.00249	0.00965	CbGbCtD
Caffeine—CYP3A4—Flutamide—prostate cancer	0.00249	0.00965	CbGbCtD
Caffeine—CYP2C9—Capecitabine—prostate cancer	0.00235	0.00909	CbGbCtD
Caffeine—CYP1A2—Conjugated Estrogens—prostate cancer	0.00225	0.00871	CbGbCtD
Caffeine—CYP2E1—Etoposide—prostate cancer	0.00223	0.00863	CbGbCtD
Caffeine—CYP3A7—Docetaxel—prostate cancer	0.00211	0.00818	CbGbCtD
Caffeine—CYP3A7-CYP3A51P—Docetaxel—prostate cancer	0.00211	0.00818	CbGbCtD
Caffeine—CYP1A2—Estradiol—prostate cancer	0.00198	0.00765	CbGbCtD
Caffeine—ABCB1—Conjugated Estrogens—prostate cancer	0.00197	0.00762	CbGbCtD
Caffeine—CYP3A4—Cabazitaxel—prostate cancer	0.00184	0.00714	CbGbCtD
Caffeine—CYP3A4—Estrone—prostate cancer	0.0018	0.00698	CbGbCtD
Caffeine—ABCB1—Mitoxantrone—prostate cancer	0.00179	0.00692	CbGbCtD
Caffeine—CYP2C9—Estradiol—prostate cancer	0.00178	0.00689	CbGbCtD
Caffeine—CYP3A5—Etoposide—prostate cancer	0.00173	0.00671	CbGbCtD
Caffeine—ABCB1—Estradiol—prostate cancer	0.00173	0.00669	CbGbCtD
Caffeine—CYP2C8—Etoposide—prostate cancer	0.00167	0.00645	CbGbCtD
Caffeine—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00161	0.00622	CbGbCtD
Caffeine—CYP3A5—Docetaxel—prostate cancer	0.00159	0.00614	CbGbCtD
Caffeine—ABCB1—Prednisone—prostate cancer	0.00149	0.00575	CbGbCtD
Caffeine—CYP1A2—Etoposide—prostate cancer	0.00129	0.00499	CbGbCtD
Caffeine—ATM—prostate gland—prostate cancer	0.0012	0.0357	CbGeAlD
Caffeine—CYP3A4—Conjugated Estrogens—prostate cancer	0.00118	0.00456	CbGbCtD
Caffeine—PRKDC—prostate gland—prostate cancer	0.00114	0.0338	CbGeAlD
Caffeine—ABCB1—Etoposide—prostate cancer	0.00113	0.00437	CbGbCtD
Caffeine—CYP3A4—Mitoxantrone—prostate cancer	0.00107	0.00415	CbGbCtD
Caffeine—PIK3CD—prostate gland—prostate cancer	0.00107	0.0317	CbGeAlD
Caffeine—CYP3A4—Estradiol—prostate cancer	0.00104	0.00401	CbGbCtD
Caffeine—ABCB1—Docetaxel—prostate cancer	0.00103	0.004	CbGbCtD
Caffeine—PRKDC—seminal vesicle—prostate cancer	0.000962	0.0285	CbGeAlD
Caffeine—PIK3CB—prostate gland—prostate cancer	0.000931	0.0276	CbGeAlD
Caffeine—RYR1—prostate gland—prostate cancer	0.000921	0.0273	CbGeAlD
Caffeine—PIK3CA—prostate gland—prostate cancer	0.000921	0.0273	CbGeAlD
Caffeine—CYP3A4—Prednisone—prostate cancer	0.00089	0.00345	CbGbCtD
Caffeine—ATM—epithelium—prostate cancer	0.000884	0.0262	CbGeAlD
Caffeine—ATM—renal system—prostate cancer	0.00082	0.0243	CbGeAlD
Caffeine—PIK3CB—seminal vesicle—prostate cancer	0.000787	0.0234	CbGeAlD
Caffeine—PIK3CD—epithelium—prostate cancer	0.000784	0.0233	CbGeAlD
Caffeine—PIK3CA—seminal vesicle—prostate cancer	0.000779	0.0231	CbGeAlD
Caffeine—ABCB1—Doxorubicin—prostate cancer	0.00077	0.00298	CbGbCtD
Caffeine—PRKDC—urethra—prostate cancer	0.000762	0.0226	CbGeAlD
Caffeine—PIK3CD—renal system—prostate cancer	0.000727	0.0216	CbGeAlD
Caffeine—CYP2D6—Doxorubicin—prostate cancer	0.000725	0.00281	CbGbCtD
Caffeine—PIK3CB—epithelium—prostate cancer	0.000684	0.0203	CbGeAlD
Caffeine—ADORA2B—prostate gland—prostate cancer	0.000678	0.0201	CbGeAlD
Caffeine—PIK3CA—epithelium—prostate cancer	0.000677	0.0201	CbGeAlD
Caffeine—CYP3A4—Etoposide—prostate cancer	0.000676	0.00262	CbGbCtD
Caffeine—PIK3CB—renal system—prostate cancer	0.000634	0.0188	CbGeAlD
Caffeine—PIK3CA—renal system—prostate cancer	0.000628	0.0186	CbGeAlD
Caffeine—PIK3CB—urethra—prostate cancer	0.000623	0.0185	CbGeAlD
Caffeine—ATM—bone marrow—prostate cancer	0.00062	0.0184	CbGeAlD
Caffeine—CYP3A4—Docetaxel—prostate cancer	0.000619	0.00239	CbGbCtD
Caffeine—PIK3CA—urethra—prostate cancer	0.000617	0.0183	CbGeAlD
Caffeine—CYP1A2—urine—prostate cancer	0.000616	0.0183	CbGeAlD
Caffeine—PRKDC—bone marrow—prostate cancer	0.000586	0.0174	CbGeAlD
Caffeine—CYP2C9—urine—prostate cancer	0.000585	0.0174	CbGeAlD
Caffeine—CYP2E1—urine—prostate cancer	0.000554	0.0164	CbGeAlD
Caffeine—PIK3CD—bone marrow—prostate cancer	0.00055	0.0163	CbGeAlD
Caffeine—ATM—testis—prostate cancer	0.00053	0.0157	CbGeAlD
Caffeine—PRKDC—testis—prostate cancer	0.000501	0.0149	CbGeAlD
Caffeine—PIK3CB—bone marrow—prostate cancer	0.00048	0.0142	CbGeAlD
Caffeine—PIK3CA—bone marrow—prostate cancer	0.000475	0.0141	CbGeAlD
Caffeine—PIK3CD—testis—prostate cancer	0.00047	0.0139	CbGeAlD
Caffeine—CYP3A4—Doxorubicin—prostate cancer	0.000461	0.00178	CbGbCtD
Caffeine—ADORA2B—urethra—prostate cancer	0.000454	0.0135	CbGeAlD
Caffeine—CYP3A4—urine—prostate cancer	0.000446	0.0132	CbGeAlD
Caffeine—CYP2D6—urine—prostate cancer	0.000439	0.013	CbGeAlD
Caffeine—PIK3CB—testis—prostate cancer	0.00041	0.0122	CbGeAlD
Caffeine—PIK3CA—testis—prostate cancer	0.000406	0.012	CbGeAlD
Caffeine—RYR1—testis—prostate cancer	0.000406	0.012	CbGeAlD
Caffeine—Oxtriphylline—PDE4D—prostate cancer	0.000401	0.265	CrCbGaD
Caffeine—ATM—lymph node—prostate cancer	0.000384	0.0114	CbGeAlD
Caffeine—PRKDC—Testosterone—Abiraterone—prostate cancer	0.000364	0.189	CbGdCrCtD
Caffeine—PRKDC—lymph node—prostate cancer	0.000363	0.0108	CbGeAlD
Caffeine—PDE4B—prostate gland—prostate cancer	0.00036	0.0107	CbGeAlD
Caffeine—Dyphylline—PDE4D—prostate cancer	0.000341	0.226	CrCbGaD
Caffeine—PIK3CD—lymph node—prostate cancer	0.000341	0.0101	CbGeAlD
Caffeine—ADORA1—renal system—prostate cancer	0.000332	0.00984	CbGeAlD
Caffeine—ADORA1—urethra—prostate cancer	0.000326	0.00967	CbGeAlD
Caffeine—CYP1B1—prostate gland—prostate cancer	0.000309	0.00916	CbGeAlD
Caffeine—ADORA2B—testis—prostate cancer	0.000299	0.00886	CbGeAlD
Caffeine—PIK3CB—lymph node—prostate cancer	0.000297	0.00882	CbGeAlD
Caffeine—PIK3CA—lymph node—prostate cancer	0.000294	0.00873	CbGeAlD
Caffeine—PIK3CA—Estradiol—Estradiol valerate/Dienogest—prostate cancer	0.000273	0.142	CbGdCrCtD
Caffeine—ADORA2A—testis—prostate cancer	0.000248	0.00737	CbGeAlD
Caffeine—Theophylline—PDE4D—prostate cancer	0.000243	0.161	CrCbGaD
Caffeine—PDE4B—urethra—prostate cancer	0.000241	0.00715	CbGeAlD
Caffeine—PIK3CA—Estradiol—Estramustine—prostate cancer	0.000232	0.12	CbGdCrCtD
Caffeine—ADORA1—testis—prostate cancer	0.000214	0.00636	CbGeAlD
Caffeine—CYP3A5—prostate gland—prostate cancer	0.000213	0.00633	CbGeAlD
Caffeine—CYP1B1—renal system—prostate cancer	0.00021	0.00624	CbGeAlD
Caffeine—CYP2E1—prostate gland—prostate cancer	0.000199	0.0059	CbGeAlD
Caffeine—PDE4B—bone marrow—prostate cancer	0.000186	0.00551	CbGeAlD
Caffeine—PIK3CA—Estradiol—Estrone—prostate cancer	0.000184	0.0957	CbGdCrCtD
Caffeine—CYP2E1—seminal vesicle—prostate cancer	0.000168	0.00499	CbGeAlD
Caffeine—PIK3CA—Estradiol—Conjugated Estrogens—prostate cancer	0.000162	0.0842	CbGdCrCtD
Caffeine—CYP2C8—renal system—prostate cancer	0.000161	0.00478	CbGeAlD
Caffeine—CYP1A1—epithelium—prostate cancer	0.00016	0.00476	CbGeAlD
Caffeine—PDE4B—testis—prostate cancer	0.000159	0.00471	CbGeAlD
Caffeine—Theobromine—CYP2E1—prostate cancer	0.000158	0.105	CrCbGaD
Caffeine—ADORA1—lymph node—prostate cancer	0.000155	0.00461	CbGeAlD
Caffeine—Theophylline—CYP1B1—prostate cancer	0.000151	0.1	CrCbGaD
Caffeine—PRKDC—Testosterone—Estramustine—prostate cancer	0.000151	0.0784	CbGdCrCtD
Caffeine—CYP1A2—renal system—prostate cancer	0.000151	0.00447	CbGeAlD
Caffeine—CYP1A1—renal system—prostate cancer	0.000149	0.00441	CbGeAlD
Caffeine—CYP1A1—urethra—prostate cancer	0.000146	0.00433	CbGeAlD
Caffeine—CYP3A5—renal system—prostate cancer	0.000145	0.00431	CbGeAlD
Caffeine—PIK3CA—Estradiol—Ethinyl Estradiol—prostate cancer	0.000136	0.0708	CbGdCrCtD
Caffeine—CYP1B1—testis—prostate cancer	0.000136	0.00403	CbGeAlD
Caffeine—CYP2E1—renal system—prostate cancer	0.000136	0.00402	CbGeAlD
Caffeine—CYP2E1—urethra—prostate cancer	0.000133	0.00395	CbGeAlD
Caffeine—Dyspnoea—Cabazitaxel—prostate cancer	0.000126	0.00245	CcSEcCtD
Caffeine—Malnutrition—Ethinyl Estradiol—prostate cancer	0.000126	0.00244	CcSEcCtD
Caffeine—Dry skin—Estradiol—prostate cancer	0.000125	0.00242	CcSEcCtD
Caffeine—Gastrointestinal disorder—Cabazitaxel—prostate cancer	0.000122	0.00237	CcSEcCtD
Caffeine—Infection—Bicalutamide—prostate cancer	0.000121	0.00234	CcSEcCtD
Caffeine—Gastritis—Estradiol—prostate cancer	0.000121	0.00234	CcSEcCtD
Caffeine—PRKDC—Testosterone—Estrone—prostate cancer	0.00012	0.0623	CbGdCrCtD
Caffeine—Rash—Estramustine—prostate cancer	0.000119	0.00232	CcSEcCtD
Caffeine—Haemoglobin—Goserelin—prostate cancer	0.000119	0.00232	CcSEcCtD
Caffeine—Dermatitis—Estramustine—prostate cancer	0.000119	0.00232	CcSEcCtD
Caffeine—Nervous system disorder—Bicalutamide—prostate cancer	0.000119	0.00231	CcSEcCtD
Caffeine—Blood creatinine increased—Mitoxantrone—prostate cancer	0.000119	0.00231	CcSEcCtD
Caffeine—Haemorrhage—Goserelin—prostate cancer	0.000119	0.00231	CcSEcCtD
Caffeine—Skin disorder—Bicalutamide—prostate cancer	0.000118	0.00229	CcSEcCtD
Caffeine—Hypercalcaemia—Epirubicin—prostate cancer	0.000117	0.00228	CcSEcCtD
Caffeine—Hypersensitivity—Estradiol valerate/Dienogest—prostate cancer	0.000116	0.00226	CcSEcCtD
Caffeine—Rash—Abiraterone—prostate cancer	0.000116	0.00225	CcSEcCtD
Caffeine—Dermatitis—Abiraterone—prostate cancer	0.000116	0.00225	CcSEcCtD
Caffeine—PDE4B—lymph node—prostate cancer	0.000115	0.00341	CbGeAlD
Caffeine—Rash—Estrone—prostate cancer	0.000114	0.00222	CcSEcCtD
Caffeine—Dermatitis—Estrone—prostate cancer	0.000114	0.00221	CcSEcCtD
Caffeine—ABCB1—prostate gland—prostate cancer	0.000113	0.00336	CbGeAlD
Caffeine—Hypersensitivity—Degarelix—prostate cancer	0.000111	0.00215	CcSEcCtD
Caffeine—Cardiac disorder—Goserelin—prostate cancer	0.00011	0.00214	CcSEcCtD
Caffeine—Cardiac disorder—Conjugated Estrogens—prostate cancer	0.000109	0.00212	CcSEcCtD
Caffeine—CYP3A4—renal system—prostate cancer	0.000109	0.00324	CbGeAlD
Caffeine—Hypercalcaemia—Doxorubicin—prostate cancer	0.000109	0.00211	CcSEcCtD
Caffeine—Dyspnoea—Bicalutamide—prostate cancer	0.000108	0.0021	CcSEcCtD
Caffeine—Pulmonary oedema—Docetaxel—prostate cancer	0.000108	0.00209	CcSEcCtD
Caffeine—CYP2D6—renal system—prostate cancer	0.000107	0.00319	CbGeAlD
Caffeine—Immune system disorder—Goserelin—prostate cancer	0.000107	0.00208	CcSEcCtD
Caffeine—Immune system disorder—Conjugated Estrogens—prostate cancer	0.000106	0.00206	CcSEcCtD
Caffeine—Hyperglycaemia—Estradiol—prostate cancer	0.000106	0.00206	CcSEcCtD
Caffeine—Rash—Nilutamide—prostate cancer	0.000106	0.00206	CcSEcCtD
Caffeine—Dermatitis—Nilutamide—prostate cancer	0.000106	0.00206	CcSEcCtD
Caffeine—Urine output increased—Capecitabine—prostate cancer	0.000106	0.00205	CcSEcCtD
Caffeine—Rash—Flutamide—prostate cancer	0.000106	0.00205	CcSEcCtD
Caffeine—Dermatitis—Flutamide—prostate cancer	0.000105	0.00205	CcSEcCtD
Caffeine—Infestation NOS—Estradiol—prostate cancer	0.000105	0.00204	CcSEcCtD
Caffeine—Infestation—Estradiol—prostate cancer	0.000105	0.00204	CcSEcCtD
Caffeine—Sepsis—Docetaxel—prostate cancer	0.000105	0.00204	CcSEcCtD
Caffeine—Gastrointestinal disorder—Bicalutamide—prostate cancer	0.000105	0.00203	CcSEcCtD
Caffeine—Hypersensitivity—Cabazitaxel—prostate cancer	0.000104	0.00202	CcSEcCtD
Caffeine—CYP2C8—testis—prostate cancer	0.000104	0.00309	CbGeAlD
Caffeine—Malnutrition—Goserelin—prostate cancer	0.000103	0.00201	CcSEcCtD
Caffeine—Malnutrition—Conjugated Estrogens—prostate cancer	0.000102	0.00199	CcSEcCtD
Caffeine—Infection—Ethinyl Estradiol—prostate cancer	0.000102	0.00198	CcSEcCtD
Caffeine—Sepsis—Capecitabine—prostate cancer	0.000102	0.00197	CcSEcCtD
Caffeine—Nervous system disorder—Ethinyl Estradiol—prostate cancer	0.000101	0.00195	CcSEcCtD
Caffeine—Nervousness—Goserelin—prostate cancer	0.0001	0.00195	CcSEcCtD
Caffeine—Skin disorder—Ethinyl Estradiol—prostate cancer	9.96e-05	0.00193	CcSEcCtD
Caffeine—Rash—Estradiol valerate/Dienogest—prostate cancer	9.96e-05	0.00193	CcSEcCtD
Caffeine—Nervousness—Conjugated Estrogens—prostate cancer	9.95e-05	0.00193	CcSEcCtD
Caffeine—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	9.95e-05	0.00193	CcSEcCtD
Caffeine—Hyperglycaemia—Mitoxantrone—prostate cancer	9.89e-05	0.00192	CcSEcCtD
Caffeine—CYP1B1—lymph node—prostate cancer	9.86e-05	0.00292	CbGeAlD
Caffeine—Deafness—Docetaxel—prostate cancer	9.81e-05	0.0019	CcSEcCtD
Caffeine—Renal failure—Mitoxantrone—prostate cancer	9.61e-05	0.00187	CcSEcCtD
Caffeine—ABCB1—seminal vesicle—prostate cancer	9.59e-05	0.00284	CbGeAlD
Caffeine—Deafness—Capecitabine—prostate cancer	9.49e-05	0.00184	CcSEcCtD
Caffeine—Rash—Degarelix—prostate cancer	9.47e-05	0.00184	CcSEcCtD
Caffeine—Haemoglobin—Estradiol—prostate cancer	9.47e-05	0.00184	CcSEcCtD
Caffeine—Dermatitis—Degarelix—prostate cancer	9.46e-05	0.00184	CcSEcCtD
Caffeine—Haemorrhage—Estradiol—prostate cancer	9.42e-05	0.00183	CcSEcCtD
Caffeine—Pulmonary oedema—Prednisone—prostate cancer	9.28e-05	0.0018	CcSEcCtD
Caffeine—PRKDC—Testosterone—Estradiol—prostate cancer	9.09e-05	0.0472	CbGdCrCtD
Caffeine—Sepsis—Prednisone—prostate cancer	9.04e-05	0.00176	CcSEcCtD
Caffeine—Convulsion—Goserelin—prostate cancer	8.96e-05	0.00174	CcSEcCtD
Caffeine—Hypersensitivity—Bicalutamide—prostate cancer	8.94e-05	0.00174	CcSEcCtD
Caffeine—Hypertension—Goserelin—prostate cancer	8.93e-05	0.00173	CcSEcCtD
Caffeine—Convulsion—Conjugated Estrogens—prostate cancer	8.88e-05	0.00172	CcSEcCtD
Caffeine—Gastrointestinal disorder—Ethinyl Estradiol—prostate cancer	8.86e-05	0.00172	CcSEcCtD
Caffeine—Haemoglobin—Mitoxantrone—prostate cancer	8.82e-05	0.00171	CcSEcCtD
Caffeine—Haemorrhage—Mitoxantrone—prostate cancer	8.78e-05	0.0017	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Docetaxel—prostate cancer	8.77e-05	0.0017	CcSEcCtD
Caffeine—CYP2E1—testis—prostate cancer	8.77e-05	0.0026	CbGeAlD
Caffeine—Cardiac disorder—Estradiol—prostate cancer	8.74e-05	0.0017	CcSEcCtD
Caffeine—Creatinine increased—Epirubicin—prostate cancer	8.56e-05	0.00166	CcSEcCtD
Caffeine—Immune system disorder—Estradiol—prostate cancer	8.51e-05	0.00165	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Capecitabine—prostate cancer	8.49e-05	0.00165	CcSEcCtD
Caffeine—Infection—Goserelin—prostate cancer	8.39e-05	0.00163	CcSEcCtD
Caffeine—ABCB1—epithelium—prostate cancer	8.33e-05	0.00247	CbGeAlD
Caffeine—Infection—Conjugated Estrogens—prostate cancer	8.31e-05	0.00161	CcSEcCtD
Caffeine—Theophylline—CYP2E1—prostate cancer	8.28e-05	0.0548	CrCbGaD
Caffeine—Nervous system disorder—Goserelin—prostate cancer	8.28e-05	0.00161	CcSEcCtD
Caffeine—Tachycardia—Goserelin—prostate cancer	8.24e-05	0.0016	CcSEcCtD
Caffeine—Injury—Prednisone—prostate cancer	8.23e-05	0.0016	CcSEcCtD
Caffeine—Nervous system disorder—Conjugated Estrogens—prostate cancer	8.2e-05	0.00159	CcSEcCtD
Caffeine—Malnutrition—Estradiol—prostate cancer	8.2e-05	0.00159	CcSEcCtD
Caffeine—Skin disorder—Goserelin—prostate cancer	8.2e-05	0.00159	CcSEcCtD
Caffeine—Theophylline—CYP1A1—prostate cancer	8.17e-05	0.054	CrCbGaD
Caffeine—Tachycardia—Conjugated Estrogens—prostate cancer	8.16e-05	0.00158	CcSEcCtD
Caffeine—Infestation NOS—Etoposide—prostate cancer	8.13e-05	0.00158	CcSEcCtD
Caffeine—Infestation—Etoposide—prostate cancer	8.13e-05	0.00158	CcSEcCtD
Caffeine—Skin disorder—Conjugated Estrogens—prostate cancer	8.12e-05	0.00158	CcSEcCtD
Caffeine—Irritability—Capecitabine—prostate cancer	8.11e-05	0.00157	CcSEcCtD
Caffeine—Dry skin—Docetaxel—prostate cancer	8.04e-05	0.00156	CcSEcCtD
Caffeine—Renal failure—Etoposide—prostate cancer	8e-05	0.00155	CcSEcCtD
Caffeine—Nervousness—Estradiol—prostate cancer	7.97e-05	0.00155	CcSEcCtD
Caffeine—Blood creatinine increased—Capecitabine—prostate cancer	7.96e-05	0.00154	CcSEcCtD
Caffeine—Creatinine increased—Doxorubicin—prostate cancer	7.92e-05	0.00154	CcSEcCtD
Caffeine—Dry skin—Capecitabine—prostate cancer	7.78e-05	0.00151	CcSEcCtD
Caffeine—ABCB1—renal system—prostate cancer	7.72e-05	0.00229	CbGeAlD
Caffeine—Rash—Bicalutamide—prostate cancer	7.65e-05	0.00149	CcSEcCtD
Caffeine—Dermatitis—Bicalutamide—prostate cancer	7.65e-05	0.00148	CcSEcCtD
Caffeine—ABCB1—urethra—prostate cancer	7.59e-05	0.00225	CbGeAlD
Caffeine—Gastrointestinal haemorrhage—Prednisone—prostate cancer	7.56e-05	0.00147	CcSEcCtD
Caffeine—Hypersensitivity—Ethinyl Estradiol—prostate cancer	7.56e-05	0.00147	CcSEcCtD
Caffeine—Agitation—Estradiol—prostate cancer	7.54e-05	0.00146	CcSEcCtD
Caffeine—Dyspnoea—Goserelin—prostate cancer	7.53e-05	0.00146	CcSEcCtD
Caffeine—Gastritis—Capecitabine—prostate cancer	7.52e-05	0.00146	CcSEcCtD
Caffeine—Dyspnoea—Conjugated Estrogens—prostate cancer	7.46e-05	0.00145	CcSEcCtD
Caffeine—Pulmonary oedema—Epirubicin—prostate cancer	7.25e-05	0.00141	CcSEcCtD
Caffeine—Irritability—Prednisone—prostate cancer	7.22e-05	0.0014	CcSEcCtD
Caffeine—Gastrointestinal disorder—Conjugated Estrogens—prostate cancer	7.22e-05	0.0014	CcSEcCtD
Caffeine—PRKDC—Danazol—Ethinyl Estradiol—prostate cancer	7.2e-05	0.0374	CbGdCrCtD
Caffeine—Hypertension—Estradiol—prostate cancer	7.08e-05	0.00137	CcSEcCtD
Caffeine—Sepsis—Epirubicin—prostate cancer	7.07e-05	0.00137	CcSEcCtD
Caffeine—CYP1A1—lymph node—prostate cancer	6.97e-05	0.00207	CbGeAlD
Caffeine—CYP2D6—testis—prostate cancer	6.94e-05	0.00206	CbGeAlD
Caffeine—Dry skin—Prednisone—prostate cancer	6.93e-05	0.00135	CcSEcCtD
Caffeine—Cardiac disorder—Etoposide—prostate cancer	6.78e-05	0.00132	CcSEcCtD
Caffeine—Infestation NOS—Docetaxel—prostate cancer	6.76e-05	0.00131	CcSEcCtD
Caffeine—Infestation—Docetaxel—prostate cancer	6.76e-05	0.00131	CcSEcCtD
Caffeine—Pulmonary oedema—Doxorubicin—prostate cancer	6.71e-05	0.0013	CcSEcCtD
Caffeine—Infection—Estradiol—prostate cancer	6.65e-05	0.00129	CcSEcCtD
Caffeine—Renal failure—Docetaxel—prostate cancer	6.64e-05	0.00129	CcSEcCtD
Caffeine—Hyperglycaemia—Capecitabine—prostate cancer	6.62e-05	0.00129	CcSEcCtD
Caffeine—Convulsion—Mitoxantrone—prostate cancer	6.62e-05	0.00129	CcSEcCtD
Caffeine—Hypertension—Mitoxantrone—prostate cancer	6.6e-05	0.00128	CcSEcCtD
Caffeine—Immune system disorder—Etoposide—prostate cancer	6.6e-05	0.00128	CcSEcCtD
Caffeine—Nervous system disorder—Estradiol—prostate cancer	6.56e-05	0.00127	CcSEcCtD
Caffeine—Infestation—Capecitabine—prostate cancer	6.54e-05	0.00127	CcSEcCtD
Caffeine—Infestation NOS—Capecitabine—prostate cancer	6.54e-05	0.00127	CcSEcCtD
Caffeine—Sepsis—Doxorubicin—prostate cancer	6.54e-05	0.00127	CcSEcCtD
Caffeine—Tachycardia—Estradiol—prostate cancer	6.53e-05	0.00127	CcSEcCtD
Caffeine—Skin disorder—Estradiol—prostate cancer	6.5e-05	0.00126	CcSEcCtD
Caffeine—PRKDC—Norethindrone—Ethinyl Estradiol—prostate cancer	6.49e-05	0.0337	CbGdCrCtD
Caffeine—Rash—Ethinyl Estradiol—prostate cancer	6.47e-05	0.00126	CcSEcCtD
Caffeine—Dermatitis—Ethinyl Estradiol—prostate cancer	6.46e-05	0.00125	CcSEcCtD
Caffeine—Renal failure—Capecitabine—prostate cancer	6.43e-05	0.00125	CcSEcCtD
Caffeine—Hypersensitivity—Goserelin—prostate cancer	6.22e-05	0.00121	CcSEcCtD
Caffeine—Infection—Mitoxantrone—prostate cancer	6.2e-05	0.0012	CcSEcCtD
Caffeine—Hypersensitivity—Conjugated Estrogens—prostate cancer	6.16e-05	0.0012	CcSEcCtD
Caffeine—Haemoglobin—Docetaxel—prostate cancer	6.1e-05	0.00118	CcSEcCtD
Caffeine—Tachycardia—Mitoxantrone—prostate cancer	6.09e-05	0.00118	CcSEcCtD
Caffeine—Haemorrhage—Docetaxel—prostate cancer	6.07e-05	0.00118	CcSEcCtD
Caffeine—Hypoglycaemia—Epirubicin—prostate cancer	6.06e-05	0.00118	CcSEcCtD
Caffeine—Skin disorder—Mitoxantrone—prostate cancer	6.06e-05	0.00118	CcSEcCtD
Caffeine—Dyspnoea—Estradiol—prostate cancer	5.97e-05	0.00116	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Epirubicin—prostate cancer	5.92e-05	0.00115	CcSEcCtD
Caffeine—Haemoglobin—Capecitabine—prostate cancer	5.9e-05	0.00115	CcSEcCtD
Caffeine—Hyperglycaemia—Prednisone—prostate cancer	5.9e-05	0.00115	CcSEcCtD
Caffeine—Haemorrhage—Capecitabine—prostate cancer	5.87e-05	0.00114	CcSEcCtD
Caffeine—ABCB1—bone marrow—prostate cancer	5.84e-05	0.00173	CbGeAlD
Caffeine—Gastrointestinal disorder—Estradiol—prostate cancer	5.78e-05	0.00112	CcSEcCtD
Caffeine—Cardiac disorder—Docetaxel—prostate cancer	5.63e-05	0.00109	CcSEcCtD
Caffeine—Hypoglycaemia—Doxorubicin—prostate cancer	5.61e-05	0.00109	CcSEcCtD
Caffeine—Dyspnoea—Mitoxantrone—prostate cancer	5.56e-05	0.00108	CcSEcCtD
Caffeine—Blood creatinine increased—Epirubicin—prostate cancer	5.54e-05	0.00108	CcSEcCtD
Caffeine—Convulsion—Etoposide—prostate cancer	5.51e-05	0.00107	CcSEcCtD
Caffeine—Hypertension—Etoposide—prostate cancer	5.49e-05	0.00107	CcSEcCtD
Caffeine—Immune system disorder—Docetaxel—prostate cancer	5.48e-05	0.00106	CcSEcCtD
Caffeine—Gastrointestinal haemorrhage—Doxorubicin—prostate cancer	5.47e-05	0.00106	CcSEcCtD
Caffeine—Cardiac disorder—Capecitabine—prostate cancer	5.45e-05	0.00106	CcSEcCtD
Caffeine—Dry skin—Epirubicin—prostate cancer	5.42e-05	0.00105	CcSEcCtD
Caffeine—Rash—Goserelin—prostate cancer	5.32e-05	0.00103	CcSEcCtD
Caffeine—Dermatitis—Goserelin—prostate cancer	5.32e-05	0.00103	CcSEcCtD
Caffeine—Immune system disorder—Capecitabine—prostate cancer	5.31e-05	0.00103	CcSEcCtD
Caffeine—Malnutrition—Docetaxel—prostate cancer	5.28e-05	0.00103	CcSEcCtD
Caffeine—Rash—Conjugated Estrogens—prostate cancer	5.27e-05	0.00102	CcSEcCtD
Caffeine—Dermatitis—Conjugated Estrogens—prostate cancer	5.27e-05	0.00102	CcSEcCtD
Caffeine—Haemoglobin—Prednisone—prostate cancer	5.26e-05	0.00102	CcSEcCtD
Caffeine—Gastritis—Epirubicin—prostate cancer	5.24e-05	0.00102	CcSEcCtD
Caffeine—Haemorrhage—Prednisone—prostate cancer	5.23e-05	0.00102	CcSEcCtD
Caffeine—Theophylline—CYP3A4—prostate cancer	5.22e-05	0.0345	CrCbGaD
Caffeine—PRKDC—Levonorgestrel—Ethinyl Estradiol—prostate cancer	5.16e-05	0.0268	CbGdCrCtD
Caffeine—Infection—Etoposide—prostate cancer	5.15e-05	0.001	CcSEcCtD
Caffeine—Blood creatinine increased—Doxorubicin—prostate cancer	5.13e-05	0.000996	CcSEcCtD
Caffeine—Malnutrition—Capecitabine—prostate cancer	5.11e-05	0.000993	CcSEcCtD
Caffeine—Tachycardia—Etoposide—prostate cancer	5.06e-05	0.000983	CcSEcCtD
Caffeine—Skin disorder—Etoposide—prostate cancer	5.04e-05	0.000978	CcSEcCtD
Caffeine—Dry skin—Doxorubicin—prostate cancer	5.02e-05	0.000974	CcSEcCtD
Caffeine—ABCB1—testis—prostate cancer	4.99e-05	0.00148	CbGeAlD
Caffeine—Hypersensitivity—Estradiol—prostate cancer	4.93e-05	0.000958	CcSEcCtD
Caffeine—Gastritis—Doxorubicin—prostate cancer	4.84e-05	0.000941	CcSEcCtD
Caffeine—Immune system disorder—Prednisone—prostate cancer	4.73e-05	0.000918	CcSEcCtD
Caffeine—Dyspnoea—Etoposide—prostate cancer	4.62e-05	0.000898	CcSEcCtD
Caffeine—Hyperglycaemia—Epirubicin—prostate cancer	4.61e-05	0.000896	CcSEcCtD
Caffeine—Hypersensitivity—Mitoxantrone—prostate cancer	4.59e-05	0.000892	CcSEcCtD
Caffeine—Convulsion—Docetaxel—prostate cancer	4.58e-05	0.000889	CcSEcCtD
Caffeine—Hypertension—Docetaxel—prostate cancer	4.56e-05	0.000886	CcSEcCtD
Caffeine—Infestation NOS—Epirubicin—prostate cancer	4.56e-05	0.000885	CcSEcCtD
Caffeine—Infestation—Epirubicin—prostate cancer	4.56e-05	0.000885	CcSEcCtD
Caffeine—Malnutrition—Prednisone—prostate cancer	4.56e-05	0.000885	CcSEcCtD
Caffeine—Renal failure—Epirubicin—prostate cancer	4.48e-05	0.00087	CcSEcCtD
Caffeine—Gastrointestinal disorder—Etoposide—prostate cancer	4.48e-05	0.00087	CcSEcCtD
Caffeine—Hypertension—Capecitabine—prostate cancer	4.42e-05	0.000857	CcSEcCtD
Caffeine—Infection—Docetaxel—prostate cancer	4.28e-05	0.000832	CcSEcCtD
Caffeine—Hyperglycaemia—Doxorubicin—prostate cancer	4.27e-05	0.000829	CcSEcCtD
Caffeine—Nervous system disorder—Docetaxel—prostate cancer	4.23e-05	0.000821	CcSEcCtD
Caffeine—Rash—Estradiol—prostate cancer	4.22e-05	0.000819	CcSEcCtD
Caffeine—Infestation—Doxorubicin—prostate cancer	4.22e-05	0.000819	CcSEcCtD
Caffeine—Infestation NOS—Doxorubicin—prostate cancer	4.22e-05	0.000819	CcSEcCtD
Caffeine—Dermatitis—Estradiol—prostate cancer	4.22e-05	0.000819	CcSEcCtD
Caffeine—Tachycardia—Docetaxel—prostate cancer	4.21e-05	0.000817	CcSEcCtD
Caffeine—Skin disorder—Docetaxel—prostate cancer	4.19e-05	0.000813	CcSEcCtD
Caffeine—Agitation—Prednisone—prostate cancer	4.19e-05	0.000813	CcSEcCtD
Caffeine—Renal failure—Doxorubicin—prostate cancer	4.15e-05	0.000805	CcSEcCtD
Caffeine—Infection—Capecitabine—prostate cancer	4.15e-05	0.000805	CcSEcCtD
Caffeine—Haemoglobin—Epirubicin—prostate cancer	4.11e-05	0.000799	CcSEcCtD
Caffeine—Nervous system disorder—Capecitabine—prostate cancer	4.09e-05	0.000795	CcSEcCtD
Caffeine—Haemorrhage—Epirubicin—prostate cancer	4.09e-05	0.000795	CcSEcCtD
Caffeine—Tachycardia—Capecitabine—prostate cancer	4.07e-05	0.000791	CcSEcCtD
Caffeine—Skin disorder—Capecitabine—prostate cancer	4.05e-05	0.000787	CcSEcCtD
Caffeine—Convulsion—Prednisone—prostate cancer	3.95e-05	0.000766	CcSEcCtD
Caffeine—Hypertension—Prednisone—prostate cancer	3.93e-05	0.000764	CcSEcCtD
Caffeine—Rash—Mitoxantrone—prostate cancer	3.93e-05	0.000764	CcSEcCtD
Caffeine—Dermatitis—Mitoxantrone—prostate cancer	3.93e-05	0.000763	CcSEcCtD
Caffeine—Dyspnoea—Docetaxel—prostate cancer	3.84e-05	0.000746	CcSEcCtD
Caffeine—Hypersensitivity—Etoposide—prostate cancer	3.82e-05	0.000742	CcSEcCtD
Caffeine—Haemoglobin—Doxorubicin—prostate cancer	3.81e-05	0.000739	CcSEcCtD
Caffeine—Cardiac disorder—Epirubicin—prostate cancer	3.8e-05	0.000738	CcSEcCtD
Caffeine—Haemorrhage—Doxorubicin—prostate cancer	3.79e-05	0.000735	CcSEcCtD
Caffeine—Gastrointestinal disorder—Docetaxel—prostate cancer	3.72e-05	0.000723	CcSEcCtD
Caffeine—Dyspnoea—Capecitabine—prostate cancer	3.72e-05	0.000723	CcSEcCtD
Caffeine—Immune system disorder—Epirubicin—prostate cancer	3.7e-05	0.000718	CcSEcCtD
Caffeine—Infection—Prednisone—prostate cancer	3.69e-05	0.000717	CcSEcCtD
Caffeine—Nervous system disorder—Prednisone—prostate cancer	3.65e-05	0.000708	CcSEcCtD
Caffeine—Tachycardia—Prednisone—prostate cancer	3.63e-05	0.000705	CcSEcCtD
Caffeine—ABCB1—lymph node—prostate cancer	3.62e-05	0.00107	CbGeAlD
Caffeine—Skin disorder—Prednisone—prostate cancer	3.61e-05	0.000701	CcSEcCtD
Caffeine—Gastrointestinal disorder—Capecitabine—prostate cancer	3.6e-05	0.0007	CcSEcCtD
Caffeine—Malnutrition—Epirubicin—prostate cancer	3.56e-05	0.000692	CcSEcCtD
Caffeine—Cardiac disorder—Doxorubicin—prostate cancer	3.51e-05	0.000682	CcSEcCtD
Caffeine—Nervousness—Epirubicin—prostate cancer	3.46e-05	0.000672	CcSEcCtD
Caffeine—Immune system disorder—Doxorubicin—prostate cancer	3.42e-05	0.000664	CcSEcCtD
Caffeine—Malnutrition—Doxorubicin—prostate cancer	3.3e-05	0.00064	CcSEcCtD
Caffeine—Agitation—Epirubicin—prostate cancer	3.27e-05	0.000636	CcSEcCtD
Caffeine—Rash—Etoposide—prostate cancer	3.27e-05	0.000635	CcSEcCtD
Caffeine—Dermatitis—Etoposide—prostate cancer	3.27e-05	0.000635	CcSEcCtD
Caffeine—Nervousness—Doxorubicin—prostate cancer	3.2e-05	0.000622	CcSEcCtD
Caffeine—Hypersensitivity—Docetaxel—prostate cancer	3.18e-05	0.000617	CcSEcCtD
Caffeine—Convulsion—Epirubicin—prostate cancer	3.09e-05	0.000599	CcSEcCtD
Caffeine—Hypertension—Epirubicin—prostate cancer	3.08e-05	0.000597	CcSEcCtD
Caffeine—Hypersensitivity—Capecitabine—prostate cancer	3.08e-05	0.000597	CcSEcCtD
Caffeine—Agitation—Doxorubicin—prostate cancer	3.03e-05	0.000588	CcSEcCtD
Caffeine—Infection—Epirubicin—prostate cancer	2.89e-05	0.000561	CcSEcCtD
Caffeine—Convulsion—Doxorubicin—prostate cancer	2.86e-05	0.000555	CcSEcCtD
Caffeine—Nervous system disorder—Epirubicin—prostate cancer	2.85e-05	0.000554	CcSEcCtD
Caffeine—Hypertension—Doxorubicin—prostate cancer	2.85e-05	0.000553	CcSEcCtD
Caffeine—Tachycardia—Epirubicin—prostate cancer	2.84e-05	0.000551	CcSEcCtD
Caffeine—Skin disorder—Epirubicin—prostate cancer	2.82e-05	0.000548	CcSEcCtD
Caffeine—Hypersensitivity—Prednisone—prostate cancer	2.74e-05	0.000532	CcSEcCtD
Caffeine—Rash—Docetaxel—prostate cancer	2.72e-05	0.000528	CcSEcCtD
Caffeine—Dermatitis—Docetaxel—prostate cancer	2.72e-05	0.000527	CcSEcCtD
Caffeine—Infection—Doxorubicin—prostate cancer	2.67e-05	0.000519	CcSEcCtD
Caffeine—Nervous system disorder—Doxorubicin—prostate cancer	2.64e-05	0.000512	CcSEcCtD
Caffeine—Rash—Capecitabine—prostate cancer	2.63e-05	0.000511	CcSEcCtD
Caffeine—Dermatitis—Capecitabine—prostate cancer	2.63e-05	0.000511	CcSEcCtD
Caffeine—Tachycardia—Doxorubicin—prostate cancer	2.63e-05	0.00051	CcSEcCtD
Caffeine—Skin disorder—Doxorubicin—prostate cancer	2.61e-05	0.000507	CcSEcCtD
Caffeine—Dyspnoea—Epirubicin—prostate cancer	2.59e-05	0.000503	CcSEcCtD
Caffeine—PRKDC—Danazol—Prednisone—prostate cancer	2.53e-05	0.0131	CbGdCrCtD
Caffeine—Gastrointestinal disorder—Epirubicin—prostate cancer	2.51e-05	0.000487	CcSEcCtD
Caffeine—Dyspnoea—Doxorubicin—prostate cancer	2.4e-05	0.000466	CcSEcCtD
Caffeine—Rash—Prednisone—prostate cancer	2.34e-05	0.000455	CcSEcCtD
Caffeine—Dermatitis—Prednisone—prostate cancer	2.34e-05	0.000455	CcSEcCtD
Caffeine—Gastrointestinal disorder—Doxorubicin—prostate cancer	2.32e-05	0.000451	CcSEcCtD
Caffeine—Hypersensitivity—Epirubicin—prostate cancer	2.14e-05	0.000416	CcSEcCtD
Caffeine—Hypersensitivity—Doxorubicin—prostate cancer	1.98e-05	0.000385	CcSEcCtD
Caffeine—Rash—Epirubicin—prostate cancer	1.83e-05	0.000356	CcSEcCtD
Caffeine—Dermatitis—Epirubicin—prostate cancer	1.83e-05	0.000356	CcSEcCtD
Caffeine—Rash—Doxorubicin—prostate cancer	1.7e-05	0.000329	CcSEcCtD
Caffeine—Dermatitis—Doxorubicin—prostate cancer	1.69e-05	0.000329	CcSEcCtD
Caffeine—CYP2C8—Metabolism—LPL—prostate cancer	3.94e-07	4.42e-06	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—IL6—prostate cancer	3.94e-07	4.42e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—NCOA1—prostate cancer	3.93e-07	4.41e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—NCOA1—prostate cancer	3.9e-07	4.38e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—SULT2A1—prostate cancer	3.89e-07	4.36e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—CYP19A1—prostate cancer	3.88e-07	4.35e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—MTHFR—prostate cancer	3.87e-07	4.34e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—KRAS—prostate cancer	3.85e-07	4.32e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—CYP19A1—prostate cancer	3.84e-07	4.31e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—SRC—prostate cancer	3.84e-07	4.3e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—MED12—prostate cancer	3.83e-07	4.29e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—COMT—prostate cancer	3.82e-07	4.29e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—GSTP1—prostate cancer	3.81e-07	4.27e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—CYP1A1—prostate cancer	3.81e-07	4.27e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PPARA—prostate cancer	3.8e-07	4.26e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GNG5—prostate cancer	3.8e-07	4.26e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—CAV1—prostate cancer	3.79e-07	4.25e-06	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—PIK3CA—prostate cancer	3.78e-07	4.24e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—CAV1—prostate cancer	3.78e-07	4.24e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—ERCC2—prostate cancer	3.78e-07	4.24e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—SLC5A5—prostate cancer	3.77e-07	4.23e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—ITPR1—prostate cancer	3.75e-07	4.2e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—RXRA—prostate cancer	3.74e-07	4.2e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—VEGFA—prostate cancer	3.74e-07	4.19e-06	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—PIK3CA—prostate cancer	3.73e-07	4.19e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—RXRA—prostate cancer	3.71e-07	4.16e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—STAT3—prostate cancer	3.7e-07	4.15e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CYP2E1—prostate cancer	3.68e-07	4.13e-06	CbGpPWpGaD
Caffeine—PIK3CB—Signaling Pathways—AKT1—prostate cancer	3.66e-07	4.11e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—NCOA3—prostate cancer	3.66e-07	4.1e-06	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—TP53—prostate cancer	3.66e-07	4.1e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PIK3CB—prostate cancer	3.65e-07	4.09e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—NQO1—prostate cancer	3.64e-07	4.09e-06	CbGpPWpGaD
Caffeine—ADORA2B—Signaling Pathways—AKT1—prostate cancer	3.63e-07	4.07e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PTGS2—prostate cancer	3.62e-07	4.06e-06	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—TP53—prostate cancer	3.61e-07	4.05e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.61e-07	4.05e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—COMT—prostate cancer	3.6e-07	4.04e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—TH—prostate cancer	3.59e-07	4.03e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—GSTP1—prostate cancer	3.59e-07	4.03e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—COMT—prostate cancer	3.57e-07	4.01e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—CAV1—prostate cancer	3.57e-07	4.01e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	3.57e-07	4e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—GSTP1—prostate cancer	3.56e-07	3.99e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CYP3A4—prostate cancer	3.55e-07	3.99e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—MTHFR—prostate cancer	3.55e-07	3.98e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—TYMS—prostate cancer	3.54e-07	3.97e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	3.54e-07	3.97e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ITPR1—prostate cancer	3.53e-07	3.96e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ITPR1—prostate cancer	3.5e-07	3.93e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—GSTM1—prostate cancer	3.5e-07	3.93e-06	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PTEN—prostate cancer	3.5e-07	3.92e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CYP1B1—prostate cancer	3.49e-07	3.92e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—HPGDS—prostate cancer	3.49e-07	3.91e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PPARA—prostate cancer	3.48e-07	3.91e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CYP2C19—prostate cancer	3.47e-07	3.89e-06	CbGpPWpGaD
Caffeine—PIK3CA—Metabolism—AKT1—prostate cancer	3.45e-07	3.88e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PIK3CG—prostate cancer	3.45e-07	3.87e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PIK3CG—prostate cancer	3.44e-07	3.86e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.44e-07	3.86e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—MYC—prostate cancer	3.44e-07	3.86e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—LPL—prostate cancer	3.43e-07	3.85e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—TGFB1—prostate cancer	3.43e-07	3.85e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—TP53—prostate cancer	3.42e-07	3.84e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.41e-07	3.83e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GSTT1—prostate cancer	3.38e-07	3.8e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ACHE—prostate cancer	3.38e-07	3.8e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—GGT1—prostate cancer	3.38e-07	3.8e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—EGFR—prostate cancer	3.36e-07	3.77e-06	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—IL6—prostate cancer	3.35e-07	3.76e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CYP2A6—prostate cancer	3.34e-07	3.75e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—TYMS—prostate cancer	3.34e-07	3.74e-06	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—EP300—prostate cancer	3.33e-07	3.74e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—NCOA1—prostate cancer	3.33e-07	3.74e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—CYP1A1—prostate cancer	3.32e-07	3.72e-06	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—IL6—prostate cancer	3.31e-07	3.71e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—TYMS—prostate cancer	3.31e-07	3.71e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—GSTM1—prostate cancer	3.3e-07	3.7e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—ERCC2—prostate cancer	3.29e-07	3.69e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CYP19A1—prostate cancer	3.28e-07	3.69e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—CAV1—prostate cancer	3.27e-07	3.67e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—GSTM1—prostate cancer	3.27e-07	3.67e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—INS—prostate cancer	3.27e-07	3.66e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—INS—prostate cancer	3.26e-07	3.66e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—AKR1C3—prostate cancer	3.25e-07	3.65e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PIK3CG—prostate cancer	3.25e-07	3.65e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PRKACB—prostate cancer	3.24e-07	3.63e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—LPL—prostate cancer	3.24e-07	3.63e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—LPL—prostate cancer	3.21e-07	3.6e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CYP17A1—prostate cancer	3.2e-07	3.59e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—CREBBP—prostate cancer	3.2e-07	3.59e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—CREBBP—prostate cancer	3.19e-07	3.58e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—KRAS—prostate cancer	3.18e-07	3.56e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—RXRA—prostate cancer	3.17e-07	3.56e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PTEN—prostate cancer	3.15e-07	3.54e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—IL6—prostate cancer	3.13e-07	3.51e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.13e-07	3.51e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—CYP1A1—prostate cancer	3.13e-07	3.51e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—ERCC2—prostate cancer	3.1e-07	3.48e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—CYP1A1—prostate cancer	3.1e-07	3.48e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—MTHFR—prostate cancer	3.09e-07	3.47e-06	CbGpPWpGaD
Caffeine—ADORA1—Signaling Pathways—AKT1—prostate cancer	3.09e-07	3.46e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.08e-07	3.46e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—INS—prostate cancer	3.08e-07	3.45e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—ERCC2—prostate cancer	3.07e-07	3.45e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—COMT—prostate cancer	3.05e-07	3.43e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—NCOA2—prostate cancer	3.05e-07	3.42e-06	CbGpPWpGaD
Caffeine—PDE4B—Signaling Pathways—AKT1—prostate cancer	3.05e-07	3.42e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—GSTP1—prostate cancer	3.04e-07	3.41e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PPARA—prostate cancer	3.03e-07	3.4e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PIK3CD—prostate cancer	3.03e-07	3.4e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PIK3CD—prostate cancer	3.03e-07	3.4e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—CREBBP—prostate cancer	3.02e-07	3.38e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—EP300—prostate cancer	3.01e-07	3.37e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ITPR1—prostate cancer	2.99e-07	3.36e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PIK3CG—prostate cancer	2.98e-07	3.35e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.94e-07	3.3e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—PIK3CA—prostate cancer	2.92e-07	3.27e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—MTHFR—prostate cancer	2.91e-07	3.27e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—SLC5A5—prostate cancer	2.91e-07	3.27e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—MTHFR—prostate cancer	2.89e-07	3.24e-06	CbGpPWpGaD
Caffeine—PIK3CA—Signaling Pathways—AKT1—prostate cancer	2.89e-07	3.24e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—NOS3—prostate cancer	2.86e-07	3.21e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PIK3CD—prostate cancer	2.86e-07	3.21e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PPARA—prostate cancer	2.86e-07	3.21e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—NOS3—prostate cancer	2.86e-07	3.21e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—CAV1—prostate cancer	2.85e-07	3.2e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CYP2E1—prostate cancer	2.84e-07	3.19e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PPARA—prostate cancer	2.83e-07	3.18e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—TYMS—prostate cancer	2.83e-07	3.17e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—TP53—prostate cancer	2.82e-07	3.17e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—INS—prostate cancer	2.82e-07	3.17e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—NQO1—prostate cancer	2.81e-07	3.16e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—GSTM1—prostate cancer	2.79e-07	3.13e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—TH—prostate cancer	2.77e-07	3.11e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—CREBBP—prostate cancer	2.76e-07	3.1e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—LPL—prostate cancer	2.74e-07	3.08e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—NOS3—prostate cancer	2.7e-07	3.03e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CYP1B1—prostate cancer	2.7e-07	3.03e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—CAV1—prostate cancer	2.69e-07	3.02e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—CAV1—prostate cancer	2.66e-07	2.99e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CYP1A1—prostate cancer	2.65e-07	2.97e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PIK3CB—prostate cancer	2.64e-07	2.97e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PIK3CB—prostate cancer	2.64e-07	2.96e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—ERCC2—prostate cancer	2.63e-07	2.95e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PIK3CD—prostate cancer	2.62e-07	2.94e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PTGS2—prostate cancer	2.62e-07	2.94e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PTGS2—prostate cancer	2.61e-07	2.93e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GGT1—prostate cancer	2.61e-07	2.93e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PIK3CG—prostate cancer	2.6e-07	2.91e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—IL6—prostate cancer	2.58e-07	2.9e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—NCOA1—prostate cancer	2.57e-07	2.89e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.55e-07	2.86e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CYP19A1—prostate cancer	2.53e-07	2.84e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PIK3CB—prostate cancer	2.49e-07	2.8e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—NOS3—prostate cancer	2.48e-07	2.78e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PTGS2—prostate cancer	2.47e-07	2.77e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—MTHFR—prostate cancer	2.47e-07	2.77e-06	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—PIK3CA—prostate cancer	2.47e-07	2.77e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—INS—prostate cancer	2.46e-07	2.76e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PIK3CG—prostate cancer	2.45e-07	2.75e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—RXRA—prostate cancer	2.45e-07	2.74e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PIK3CG—prostate cancer	2.43e-07	2.72e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PPARA—prostate cancer	2.42e-07	2.72e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—CREBBP—prostate cancer	2.41e-07	2.7e-06	CbGpPWpGaD
Caffeine—ADORA2A—Signaling Pathways—AKT1—prostate cancer	2.38e-07	2.68e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—COMT—prostate cancer	2.36e-07	2.64e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GSTP1—prostate cancer	2.35e-07	2.63e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—INS—prostate cancer	2.32e-07	2.6e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ITPR1—prostate cancer	2.31e-07	2.59e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—INS—prostate cancer	2.3e-07	2.58e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PIK3CB—prostate cancer	2.28e-07	2.56e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PTEN—prostate cancer	2.28e-07	2.56e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PIK3CD—prostate cancer	2.28e-07	2.56e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PTEN—prostate cancer	2.28e-07	2.56e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CAV1—prostate cancer	2.28e-07	2.55e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—CREBBP—prostate cancer	2.27e-07	2.55e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PTGS2—prostate cancer	2.26e-07	2.54e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—CREBBP—prostate cancer	2.25e-07	2.52e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—PIK3CA—prostate cancer	2.22e-07	2.5e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—TYMS—prostate cancer	2.18e-07	2.45e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—EP300—prostate cancer	2.18e-07	2.44e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.17e-07	2.44e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—EP300—prostate cancer	2.17e-07	2.44e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—NOS3—prostate cancer	2.16e-07	2.42e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—GSTM1—prostate cancer	2.16e-07	2.42e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PTEN—prostate cancer	2.15e-07	2.42e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PIK3CD—prostate cancer	2.15e-07	2.41e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PIK3CD—prostate cancer	2.13e-07	2.39e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—LPL—prostate cancer	2.12e-07	2.37e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PIK3CG—prostate cancer	2.07e-07	2.33e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—EP300—prostate cancer	2.05e-07	2.3e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CYP1A1—prostate cancer	2.04e-07	2.29e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—NOS3—prostate cancer	2.03e-07	2.28e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—ERCC2—prostate cancer	2.03e-07	2.27e-06	CbGpPWpGaD
Caffeine—CYP1B1—Metabolism—AKT1—prostate cancer	2.02e-07	2.26e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—NOS3—prostate cancer	2.01e-07	2.26e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PIK3CB—prostate cancer	1.99e-07	2.23e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PTEN—prostate cancer	1.97e-07	2.22e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PTGS2—prostate cancer	1.97e-07	2.21e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—INS—prostate cancer	1.96e-07	2.2e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—CREBBP—prostate cancer	1.92e-07	2.16e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—MTHFR—prostate cancer	1.9e-07	2.14e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—EP300—prostate cancer	1.88e-07	2.11e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PIK3CB—prostate cancer	1.88e-07	2.1e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PPARA—prostate cancer	1.87e-07	2.1e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PIK3CB—prostate cancer	1.86e-07	2.09e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PTGS2—prostate cancer	1.86e-07	2.09e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PTGS2—prostate cancer	1.84e-07	2.07e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PIK3CD—prostate cancer	1.82e-07	2.05e-06	CbGpPWpGaD
Caffeine—CYP3A7—Metabolism—AKT1—prostate cancer	1.82e-07	2.04e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CAV1—prostate cancer	1.76e-07	1.97e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—NOS3—prostate cancer	1.72e-07	1.93e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PTEN—prostate cancer	1.72e-07	1.93e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—EP300—prostate cancer	1.64e-07	1.84e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PTEN—prostate cancer	1.62e-07	1.82e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—PIK3CA—prostate cancer	1.61e-07	1.81e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—PIK3CA—prostate cancer	1.61e-07	1.8e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PTEN—prostate cancer	1.61e-07	1.8e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.6e-07	1.8e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PIK3CB—prostate cancer	1.59e-07	1.78e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PTGS2—prostate cancer	1.57e-07	1.77e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—EP300—prostate cancer	1.55e-07	1.73e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—EP300—prostate cancer	1.53e-07	1.72e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—PIK3CA—prostate cancer	1.52e-07	1.7e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—INS—prostate cancer	1.51e-07	1.7e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—CREBBP—prostate cancer	1.48e-07	1.66e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.41e-07	1.58e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—PIK3CA—prostate cancer	1.39e-07	1.56e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PTEN—prostate cancer	1.37e-07	1.54e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—NOS3—prostate cancer	1.33e-07	1.49e-06	CbGpPWpGaD
Caffeine—CYP2E1—Metabolism—AKT1—prostate cancer	1.32e-07	1.48e-06	CbGpPWpGaD
Caffeine—CYP3A5—Metabolism—AKT1—prostate cancer	1.31e-07	1.47e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—EP300—prostate cancer	1.31e-07	1.47e-06	CbGpPWpGaD
Caffeine—CYP1A1—Metabolism—AKT1—prostate cancer	1.24e-07	1.39e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.23e-07	1.38e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PTGS2—prostate cancer	1.22e-07	1.36e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—PIK3CA—prostate cancer	1.21e-07	1.36e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—PIK3CA—prostate cancer	1.14e-07	1.28e-06	CbGpPWpGaD
Caffeine—CYP2C8—Metabolism—AKT1—prostate cancer	1.14e-07	1.28e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—PIK3CA—prostate cancer	1.13e-07	1.27e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PTEN—prostate cancer	1.06e-07	1.19e-06	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—EP300—prostate cancer	1.01e-07	1.13e-06	CbGpPWpGaD
Caffeine—ABCB1—Metabolism—AKT1—prostate cancer	9.91e-08	1.11e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—PIK3CA—prostate cancer	9.69e-08	1.09e-06	CbGpPWpGaD
Caffeine—CYP2D6—Metabolism—AKT1—prostate cancer	9.34e-08	1.05e-06	CbGpPWpGaD
Caffeine—CYP2C9—Metabolism—AKT1—prostate cancer	9.26e-08	1.04e-06	CbGpPWpGaD
Caffeine—CYP1A2—Metabolism—AKT1—prostate cancer	7.91e-08	8.88e-07	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—PIK3CA—prostate cancer	7.48e-08	8.39e-07	CbGpPWpGaD
Caffeine—CYP3A4—Metabolism—AKT1—prostate cancer	6.11e-08	6.85e-07	CbGpPWpGaD
